Drug Trial Radar · NCT00938717
Trial of Linaclotide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Last checked: Nov 19, 2026Latest source record: Nov 5, 2013 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
805
Actual
Start
Jul 2009
Primary completion
Sep 2010
Study completion Sep 2010
Sponsor
- Lead sponsor
- Ironwood Pharmaceuticals, Inc.Industry
- Sponsor type
- Industry
- Collaborators
- Forest Laboratories
- First posted
- Jul 14, 2009
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to determine the safety and efficacy of linaclotide administered to patients with Irritable Bowel Syndrome with Constipation (IBS-C).
Conditions
- Irritable Bowel Syndrome With Constipation
Interventions
Linaclotide or Matching PlaceboDrug
Linaclotide or Matching Placebo, administered orally, once daily, for the duration of the trial
Primary outcomes
What the sponsor says the trial is designed to measure.
- Abdominal Pain and Complete Spontaneous Bowel Movement (APC) Responder, 9 Out of 12 WeeksTime frame: Change from Baseline to Week 12
- Complete Spontaneous Bowel Movement (CSBM) 3+1 Responder, 9 Out of 12 WeeksTime frame: Change from Baseline to Week 12
- Abdominal Pain Responder, 9 Out of 12 WeeksTime frame: Change from Baseline to Week 12
- Abdominal Pain and Complete Spontaneous Bowel Movement (APC) Responder, 6 Out of 12 WeeksTime frame: Change from Baseline to Week 12
Locations
107 sites in 1 country. Site status is shown where the registry gives one.
Ironwood Investigational Site
Birmingham, Alabama
Ironwood Investigational Site
Huntsville, Alabama
Ironwood Investigational Site
Phoenix, Arizona
Ironwood Investigational Site
Tempe, Arizona
Ironwood Investigational Site
Tucson, Arizona
Ironwood Investigational Site
Tucson, Arizona
Ironwood Investigational Site
Sherwood, Arkansas
Ironwood Investigational Site
Anaheim, California
Ironwood Investigational Site
Chula Vista, California
Ironwood Investigational Site
Encinitas, California
Ironwood Investigational Site
Garden Grove, California
Ironwood Investigational Site
Laguna Hills, California
Ironwood Investigational Site
Orange, California
Ironwood Investigational Site
San Carlos, California
Ironwood Investigational Site
San Diego, California
Ironwood Investigational Site
San Diego, California
Ironwood Investigational Site
San Diego, California
Ironwood Investigational Site
Colorado Springs, Colorado
Ironwood Investigational Site
Bristol, Connecticut
Ironwood Investigational Site
Boynton Beach, Florida
Ironwood Investigational Site
Hollywood, Florida
Ironwood Investigational Site
Inverness, Florida
Ironwood Investigational Site
Jacksonville, Florida
Ironwood Investigational Site
Jacksonville, Florida
Ironwood Investigational Site
Lauderdale Lakes, Florida
Ironwood Investigational Site
Miami, Florida
Ironwood Investigational Site
Pinellas Park, Florida
Ironwood Investigational Site
Tampa, Florida
Ironwood Investigational Site
Newnan, Georgia
Ironwood Investigational Site
Peoria, Illinois
Ironwood Investigational Site
Anderson, Indiana
Ironwood Investigational Site
Clive, Iowa
Ironwood Investigational Site
Davenport, Iowa
Ironwood Investigational Site
Mission, Kansas
Ironwood Investigational Site
Overland Park, Kansas
Ironwood Investigational Site
Topeka, Kansas
Ironwood Investigational Site
Baton Rouge, Louisiana
Ironwood Investigational Site
Metairie, Louisiana
Ironwood Investigational Site
Monroe, Louisiana
Ironwood Investigational Site
Shreveport, Louisiana
Showing 40 of 107 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.